Form D · Other Health Care

Theravida, Inc.

Chapel Hill, NC · CIK 0001404578

Offering snapshot reported Feb 21, 2023 · SEC filing

Reported sold
$200K
Offering amount: $200K
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 21, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 21, 2023Initial$200,000No comparison3SEC filing
Mar 23, 2012Amendment$8,904,894$5,266,667vs Jul 6, 20106SEC filing
Jul 6, 2010Initial$3,638,227No comparison6SEC filing
Mar 13, 2009PaperNot reportedNo comparisonNot reportedSEC filing
Nov 6, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Jun 23, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Jun 25, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Jun 25, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-473971

Source: Form D, filed Feb 21, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Roger L. Flugel Director, Executive
Nasser J. Kazeminy Director
Assad Kazeminy Director
Benjamin F. Mc Graw Iii Director, Executive
Fred A. Middleton Director
Curtis L. Mo Executive
Mehdi Paborji Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
1011 S. Hamilton Road, Suite 300
Chapel Hill, NC, 27517